C07J 31/00

Sub-Class

Watch

Stats

Description

Class  C07J : STEROIDS


Subclass 31/00: Normal steroids containing one or more sulfur atoms not belonging to a hetero ring

Recent Patents

Patent #TitleFiling DateIssue DatePatent Owner
12226423 Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharideJun 28, 22Feb 18, 25Virginia Commonwealth University; Durect Corporation; The United States Government as Represented by the Department of Veterans Affairs;
12201640 19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereofDec 23, 21Jan 21, 25SAGE THERAPEUTICS, INC.
12204245 Positive resist composition and patterning processSep 24, 21Jan 21, 25Shin-Etsu Chemical Co. Ltd.
12129275 Neuroactive steroids, compositions, and uses thereofMar 29, 22Oct 29, 24SAGE THERAPEUTICS, INC.
12129276 Oxysterols and methods of use thereofMar 02, 23Oct 29, 24SAGE THERAPEUTICS, INC.
12065463 Compositions and methods for treating CNS disordersOct 24, 22Aug 20, 24SAGE THERAPEUTICS, INC.
RE49949 Reducing risk of contracting clostridium-difficile associated diseaseJan 09, 20Apr 30, 24The Board of Regents of the Nevada System of Higher Education on Behalf of the University of Nevada, Las Vegas
11970435 Taste-modified creatine salts, compounds, compositions and uses thereofMay 07, 18Apr 30, 24Augusta University Research Institute, Inc.
11945836 Compositions and methods for treating CNS disordersOct 04, 22Apr 02, 24SAGE THERAPEUTICS, INC.
11926646 C7 substituted oxysterols and methods of use thereofSep 15, 21Mar 12, 24SAGE THERAPEUTICS, INC.
11912737 19-nor neuroactive steroids and methods of use thereofOct 09, 20Feb 27, 24Sage Therpeutics, Inc.
11814408 Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereofFeb 17, 21Nov 14, 23NICOX OPHTHALMICS, INC
11732000 Oxysterols and methods of use thereofAug 06, 21Aug 22, 23SAGE THERAPEUTICS, INC.
11667666 Methods and compositions for treatment of cancerJan 19, 21Jun 06, 23CFD Research Corporation
11578097 Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereofNov 25, 15Feb 14, 23Enanta Pharmaceuticals, Inc.
11542297 Compositions and methods for treating CNS disordersMar 15, 22Jan 03, 23SAGE THERAPEUTICS, INC.
11530237 Compositions and methods for treating CNS disordersJan 21, 20Dec 20, 22SAGE THERAPEUTICS, INC.
11479577 Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acidFeb 26, 21Oct 25, 22NZP UK Limited
11406646 Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharideNov 10, 20Aug 09, 22Virginia Commonwealth University; Durect Corporation; The United States Government as Represented by the Department of Veterans Affairs;
11384115 Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosisOct 01, 20Jul 12, 22Virginia Commonwealth University

more results

Recent Publications

Publication #TitleFiling DatePub DatePatent Owner
2025/0042,934 COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERSFeb 20, 24Feb 06, 25Not available
2025/0034,201 PRODRUGS OF GANAXOLONESep 05, 24Jan 30, 25Not available
2024/0425,545 25-Hydroxy-Cholest-5-En-3-Sulfate Choline and Methods for Preparing, and Uses of, SameJun 24, 22Dec 26, 24Not available
2024/0408,124 GPX4 Inhibitors and Senolytic Compounds and Uses ThereofMay 30, 24Dec 12, 24Not available
2024/0398,834 FARNESOID X RECEPTOR MODULATORSAug 12, 24Dec 05, 24Not available
2024/0368,213 COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERSJun 12, 24Nov 07, 24Not available
2024/0300,995 C7 SUBSTITUTED OXYSTEROLS AND METHODS OF USE THEREOFFeb 01, 24Sep 12, 24Not available
2024/0287,126 NOVEL SYNTHESIS OF CHOLESTEROLMay 13, 22Aug 29, 24CORDENPHARMA INTERNATIONAL; Otto-von-Guericke-Universität Magdeburg;
2024/0228,527 STEREOSELECTIVE C9-C10 BOND FORMATIONApr 14, 22Jul 11, 24Not available
2024/0218,010 Methods of Producing Sulfated Oligosaccharide Derivatives and Intermediates ThereofMar 04, 22Jul 04, 24Not available
2024/0218,013 Process for the preparation of B-[(7alpha,17beta)-17-hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl) sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]-boronic acid and intermediates of said processOct 29, 21Jul 04, 24Not available
2024/0174,711 PROCESS FOR PREPARING B-[(7a, 1713)-17-HYDROXY-7-[9-[(4,4,5,5,5-PENTAFLUOROPENTYL)SULFINYL]NONYL]ESTRA-1,3,5(10)-TRIEN-3-YL]-BORONIC ACIDMar 29, 22May 30, 24Not available
2023/0365,619 CRYSTALLINE SODIUM CHOLESTERYL SULFATEOct 11, 21Nov 16, 23Not available
2023/0365,618 CRYSTALLINE THIOCHOLESTEROLOct 11, 21Nov 16, 23Not available
2023/0357,308 CRYSTALLINE SODIUM CHOLESTERYL SULFONATEOct 11, 21Nov 09, 23Not available
2023/0056,273 CRYSTALLINE AND LIQUID CRYSTALLINE 25-HYDROXY-CHOLEST-5-EN-3-SULFATE SODIUM AND METHODS FOR PREPARING SAMEDec 23, 20Feb 23, 23Not available
2022/0402,965 STEROL ANALOGS AND USES THEREOFSep 19, 19Dec 22, 22Not available
2022/0396,597 NMDAR INHIBITING AGENTS AND GABAAR POTENTIATING AGENTS AND USES THEREOFOct 16, 20Dec 15, 22Washington University
2022/0259,257 PROCESS FOR THE PREPARATION OF FULVESTRANTFeb 04, 22Aug 18, 22FARMABIOS S.P.A.
2022/0204,548 SMALL MOLECULE MODULATORS OF GUT BACTERIAL BILE ACID METABOLISMMay 08, 20Jun 30, 22President and Fellows of Harvard College

more results

Top Owners in This Subclass

Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More

Patents Issued To Date - By Filing Year

Average Time to Issuance